Janus Henderson Group plc

Equities

JHG

JE00BYPZJM29

Investment Management & Fund Operators

Real-time Estimate Cboe BZX Other stock markets 11:19:19 2024-04-19 am EDT			5-day change	1st Jan Change
30.63 ^USD	+0.53%		-3.50%	+1.56%

Apr. 12	UBS Adjusts Janus Henderson Group Price Target to $30 From $28, Maintains Sell Rating	MT
Apr. 02	Goldman Sachs Raises Janus Henderson's Price Target to $32 From $29, Keeps Sell Rating	MT

DTx Pharma, LLC announced that it has received $100 million in funding from a group of investors

March 28, 2021

On March 1, 2021, DTx Pharma, LLC closed the transaction. The company has received $100,000,000 in the transaction led by new investor, RA Capital Management, L.P. and involved participation from new investors, Access Biotechnology, Citadel Multi-Strategy Equities Master Fund Ltd., a fund managed by Citadel Advisors LLC, Cormorant Asset Management, LLC, Janus Henderson Group plc (NYSE:JHG), and Logos Global Management, L.P., returning investors including Friedman BioVenture Fund, ExSight Ventures, Eli Lilly and Company (NYSE:LLY), and Viva BioInnovator. As a part of the transaction, Matthew Hammond of RA Capital Management, L.P. and Dan Becker of Access Biotechnology has joined the company's board of directors.

The company has received $99,999,985.24 pursuant to exemption provided under Regulation D from 22 investors.

Latest news about Janus Henderson Group plc

UBS Adjusts Janus Henderson Group Price Target to $30 From $28, Maintains Sell Rating	Apr. 12	MT
Goldman Sachs Raises Janus Henderson's Price Target to $32 From $29, Keeps Sell Rating	Apr. 02	MT
Focus on bitcoin in Q1 overshadows broadening of US ETF landscape	Apr. 01	RE
Edgy Insights: The gross profitability premium	Mar. 27
Janus Henderson Group plc Announces Executive Changes, Effective April 12, 2024	Mar. 15	CI
Henderson European and Eurotrust to merge into GBP700 million investor	Mar. 14	AN
Janus Henderson Sustainable Credit Active ETF Declares Final Distribution	Mar. 04	MT
Janus Henderson Group Insider Sold Shares Worth $682,868, According to a Recent SEC Filing	Mar. 01	MT
Janus Henderson Group Insider Sold Shares Worth $301,717, According to a Recent SEC Filing	Mar. 01	MT
Applied Therapeutics, Inc. announced that it has received $99.997998 million in funding from a group of investors	Feb. 29	CI
Transcript : Janus Henderson Group plc Presents at UBS Financial Services Conference 2024, Feb-28-2024 08:50 AM	Feb. 28
Applied Therapeutics, Inc. announced that it expects to receive $99.997998 million in funding from a group of investors	Feb. 26	CI
Beer time? Investors tempted by brewers as spirits sales falter	Feb. 23	RE
Beer time? Investors tempted by brewers as spirits sales falter	Feb. 23	RE
Nikkei parties like it's 1989; scales record high	Feb. 21	RE
Transcript : Janus Henderson Group plc Presents at Bank of America Securities Financial Services Conference 2024, Feb-20-2024 03:00 PM	Feb. 20
Janus Henderson Group plc Appoints Victoria Mio as Head of Greater China Equities	Feb. 15	CI
Mersen: Janus Henderson falls below 5% of share capital	Feb. 14	CF
Supermarket group Ahold Delhaize reassures investors with cost cuts	Feb. 14	RE
Analysis-Investors hope strong US economy can insulate stocks from yield surge	Feb. 14	RE
Attralus, Inc. announced that it has received $172.599821 million in funding from a group of investors	Feb. 05	CI
UBS Adjusts Janus Henderson Group Price Target to $28 From $27, Maintains Sell Rating	Feb. 05	MT
Novo Holdings A/S entered into an agreement to acquire Catalent, Inc. from Elliott Investment Management L.P. and other for $11.7 billion.	Feb. 04	CI
JPMorgan Upgrades Janus Henderson to Neutral From Underweight, Adjusts Price Target to $31 From $28	Feb. 02	MT
Mersen: Janus Henderson Investors UK tops the 5% mark	Feb. 01	CF

Chart Janus Henderson Group plc

Duration

Period

More charts

Company Profile

Janus Henderson Group plc is a United Kingdom-based independent global asset manager, which is specializing in active investment across various asset classes. The Company manages a broad range of investment products for institutional and retail investors across four capabilities: equities, fixed income, multi-asset and alternatives. Its intermediary channel distributes United States mutual funds, separately managed accounts, exchange-traded funds and various others, through financial intermediaries, including banks, financial advisors and discretionary wealth managers. Its self-directed channel serves individual investors who invest in its products through a mutual fund supermarket or directly with the Company. Its institutional channel serves corporations, endowments, pension funds and others, with distribution direct to the plan sponsor and through consultants. It has operations in North America, the United Kingdom, continental Europe, Latin America, Japan, Asia and Australia.

Sector

Investment Management & Fund Operators

Calendar

2024-04-30 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

INTERVIEW - Ali Dibadj, CEO of Janus Henderson: Cash is a real competitor

March 30, 2023 at 05:21 pm EDT

More Strategies

Ratings for Janus Henderson Group plc

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

30.47 USD

Average target price

31.12 USD

Spread / Average Target

+2.13%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Investment Management & Fund Operators

	1st Jan change	Capi.
JANUS HENDERSON GROUP PLC	+1.56%	4.91B
BLACKROCK, INC.	-7.62%	111B
UBS GROUP AG	-2.03%	90.88B
APOLLO GLOBAL MANAGEMENT, INC.	+15.14%	60.96B
BROOKFIELD CORPORATION	+0.47%	58.51B
AMERIPRISE FINANCIAL, INC.	+9.18%	41.34B
BANK OF NEW YORK MELLON CORPORATION (THE)	+8.03%	41.32B
3I GROUP PLC	+17.12%	34.21B
T. ROWE PRICE GROUP INC.	+1.32%	24.31B
STATE STREET CORPORATION	-4.98%	22.02B

Other Investment Management & Fund Operators